ISETbyRarecells - Isolation by Size of Tumor cells

IsetbyRarecells : The ISET® technology is the fruit of 20 years of research of Patrizia Paterlini-Brechot and her team at Université Paris Descartes and INSERM.

Rarecells Diagnostics is hiring!

News

[OPPORTUNITY] – Rarecells is looking to hire a Research Lab Director! 🧬🦠🔬 For more info: www.rarecells.com/careers

Read More
Egorà – Interview with Prof. Paterlini-Bréchot

News

Prof. Patrizia Paterlini-Bréchot, Scientific Advisor of Rarecells Diagnostics, has been interviewed by the magazine Egorà about the recent developments for the ISET Blood Cytopathology and the application of Circulating Tumor Cells (CTC) in early detection of cancer.

Read More
EPO Inventor Awards 2019 – Prof. Paterlini-Bréchot named finalist

News

The European Patent Office (EPO) has nominated Professor Patrizia Paterlini-Bréchot, as one of the three finalists of the European Inventor Award 2019 – category “Research”- for developing ISET ®, a new diagnostic blood test for cancer. The highly-sensitive ISET ® test detects circulating tumour cells which play a key role in spreading cancer to other […]

Read More
WIC-F Global Paris 2019 – March the 28th at 12:15 pm

Actualités

As invited speaker, Prof. Paterlini-Bréchot will animate the session « Scaling up international efforts to tackle global health and quality of life challenges » at the Women Influence Forum 2019. The session will take place in Paris on the 28th of March 2019 at 12:15 pm. More information at: http://www.womeninfluence.club/projects/paris-28-29-march-2019/

Read More
“Demain, tuer le cancer?” – the Conference of Prof. Paterlini-Bréchot, Scientific Advisor of Rarecells Diagnostics – March the 26th, 2019 at 7:00 pm

Actualités

As invited speaker, Prof. Paterlini-Bréchot will animate a conference in Paris on the 26th of March 2019 at 9:00 pm entitled “Demain, tuer le cancer?”. Further information here: http://di-re.org/2019/03/27-03-demain-tuer-le-cancer/

Read More

Iset by Rarecells

The gold standard technology for Circulating Cancer Cells

IsetbyRarecells : The ISET® technology is the fruit of 20 years of research of Patrizia Paterlini-Brechot and her team at Université Paris Descartes and INSERM.